1. Home
  2. RANI vs GDHG Comparison

RANI vs GDHG Comparison

Compare RANI & GDHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • GDHG
  • Stock Information
  • Founded
  • RANI 2012
  • GDHG 2008
  • Country
  • RANI United States
  • GDHG China
  • Employees
  • RANI N/A
  • GDHG N/A
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • GDHG Services-Misc. Amusement & Recreation
  • Sector
  • RANI Health Care
  • GDHG Consumer Discretionary
  • Exchange
  • RANI Nasdaq
  • GDHG Nasdaq
  • Market Cap
  • RANI 17.0M
  • GDHG 20.1M
  • IPO Year
  • RANI 2021
  • GDHG 2023
  • Fundamental
  • Price
  • RANI $0.54
  • GDHG $1.20
  • Analyst Decision
  • RANI Strong Buy
  • GDHG
  • Analyst Count
  • RANI 4
  • GDHG 0
  • Target Price
  • RANI $7.75
  • GDHG N/A
  • AVG Volume (30 Days)
  • RANI 323.8K
  • GDHG 1.2M
  • Earning Date
  • RANI 08-05-2025
  • GDHG 07-29-2025
  • Dividend Yield
  • RANI N/A
  • GDHG N/A
  • EPS Growth
  • RANI N/A
  • GDHG N/A
  • EPS
  • RANI N/A
  • GDHG N/A
  • Revenue
  • RANI $1,200,000.00
  • GDHG $22,333,251.00
  • Revenue This Year
  • RANI N/A
  • GDHG N/A
  • Revenue Next Year
  • RANI N/A
  • GDHG N/A
  • P/E Ratio
  • RANI N/A
  • GDHG N/A
  • Revenue Growth
  • RANI N/A
  • GDHG N/A
  • 52 Week Low
  • RANI $0.46
  • GDHG $0.51
  • 52 Week High
  • RANI $4.19
  • GDHG $266.25
  • Technical
  • Relative Strength Index (RSI)
  • RANI 42.19
  • GDHG 33.41
  • Support Level
  • RANI $0.50
  • GDHG $0.51
  • Resistance Level
  • RANI $0.60
  • GDHG $1.72
  • Average True Range (ATR)
  • RANI 0.03
  • GDHG 0.24
  • MACD
  • RANI 0.02
  • GDHG 0.34
  • Stochastic Oscillator
  • RANI 42.04
  • GDHG 62.37

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

Share on Social Networks: